C.PapassideriI
Our approach remains consistent regardless of dosage changeswe prioritize your safety and your results above all else
This issue of MIND Matters celebrates the people doing this work, including some new members of our team (p 7), the trainees who are acquiring skills and knowledge to lead this work (p 6), the progress being made by investigators (p 5), and an amazing research participant and advocate, Julie Moore (p 1 and 3) who has been recognized for her remarkable leadership
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update
Sermorelin Before and After: A Realistic Week-by-Week Look at Results You have probably searched "sermorelin before and after" more than once, scrolling through dramatic photos and bold claims while quietly wondering: what will actually happen to me, and how fast
Patients on this protocol who also use metabolic support agents like Metformin should note that both agents activate AMPK, and physician oversight is warranted to avoid compounding effects on blood glucose that could theoretically cause hypoglycemia in susceptible individuals, though this has not been reported clinically with MOTS-c at standard doses
